FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

Weiner Moves to Foreign Inspections Office

FDA Office of Combination Products associate director for policy John Weiner moves to Office of Global Operations director, where he will oversee the ...

latest-news-card-1
Medical Devices

Boston Scientific Recalls PolarSheath Steerable

Boston Scientific recalls the PolarSheath Steerable Sheath 12F after the company identified a tooling error in manufacturing which may have caused del...

latest-news-card-1
Medical Devices

Magnetic Stimulation for Adolescent Depression Cleared

FDA clears a Neuronetics 510(k) for its NeuroStar Advanced Therapy for use as an adjunct for treating major depressive disorder in adolescent patients...

Medical Devices

FDA Approves Medtronic Evolut FX+

FDA approves the latest version of Medtronics Evolut FX+ system to treat symptomatic severe aortic stenosis.

latest-news-card-1
Human Drugs

Revised BA/BE Sample Handling Guidance

FDA issues a revised final and draft guidance on the handling and retention of BA and BE testing samples.

latest-news-card-1
Human Drugs

Bioresearch Monitoring Issues at New York Site

FDA warns Dr. Bret Rutherford about violations in his work as a clinical study investigator at the New York State Psychiatric Institute.

latest-news-card-1
Biologics

Mesoblast Refiling BLA for Remestemcel-L

Mesoblast says it will refile its BLA for remestemcel-L for treating pediatric steroid-refractory acute graft versus host disease following favorable...

latest-news-card-1
Human Drugs

FDA Warns Against Topical OTC Analgesics

FDA issues a warning to not use certain over-the-counter analgesic products that are marketed for topical use to relieve pain before, during or after ...

latest-news-card-1
Federal Register

PARP Inhibitor Ovarian Cancer Indications Withdrawn

Federal Register notice: FDA announces that it is withdrawing approval of the indications for treating adult patients with advanced ovarian cancer for...

latest-news-card-1
Human Drugs

CGMP Violations at Deqing Jiarou

FDA warns Chinas Deqing Jiarou Daily Chemical Co. about CGMP violations in its production of finished drugs.